Last reviewed · How we verify
NCT03975348
Ventilation Distribution After Bariatric Surgery
NA trial testing High flow nasal cannula in Bariatric Surgery Candidate in 15 participants. Completed in 30 September 2019.
30 September 2019
Quick facts
| Lead sponsor | University of Trieste |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 15 |
| Start date | 15 April 2019 |
| Primary completion | 30 September 2019 |
| Estimated completion | 30 September 2019 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- High flow nasal cannula
- Continuous positive airway pressure
- Facemask
Conditions studied
- Bariatric Surgery Candidate — all drugs for Bariatric Surgery Candidate →
- Atelectasis, Postoperative Pulmonary — all drugs for Atelectasis, Postoperative Pulmonary →
Sponsor
University of Trieste
Who can join
18 and older, any sex, with Bariatric Surgery Candidate or Atelectasis, Postoperative Pulmonary. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Obese patients have an increased risk of developing post-operative respiratory complications due to their comorbidities. They have a restrictive ventilatory defect with reduction of lung volumes and expiratory flow limitation, higher airway resistance and collapsibility of the upper respiratory tract. These abnormalities are worsened by general anesthesia and opioid administration. It has been proved that oxygen therapy with HFNC (high flow nasal cannula) increases lung volumes through a continuous positive airway pressure (CPAP)-effect. This also improves gas exchange and decreases anatomical dead space. At the present time, CPAP represents the gold standard for the prevention of postoperative pulmonary complications. The purpose of this study is to evaluate lung ventilation, gas exchange and comfort with HFNC compared with CPAP during the post-operative period in patients who undergo laparoscopic bariatric surgery.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Lung Volume and Ventilation Distribution After Bariatric Surgery: High-Flow Nasal Cannula Versus CPAP.
Lena E, Comuzzi L, Ajčević M, Tarchini M, et al · · 2024 · PMID 38744475 · DOI 10.4187/respcare.11356
Verify or expand the search:
- PubMed search for NCT03975348
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of High flow nasal cannula
Trials testing the same drug.
- NCT06069817 — Impact of High Flow Therapy on Complications Related to Airway Stenting · NA · unknown
- NCT05918575 — Postextubation Use of Noninvasive Respiratory Support in Severely Obese Patients · NA · recruiting
- NCT05532033 — High Flow Nasal Cannula and Diaphragmatic Function · NA · completed
- NCT04842253 — HFNC Vs LFNC in Patients with AF Undergoing RFCA Under Deep Sedation. · NA · terminated
- NCT04849520 — High Flow Nasal Cannula for Safe Apnea · NA · completed
Other recruiting trials for Bariatric Surgery Candidate
Currently open trials in the same condition.
- NCT07525232 — Stepwise PEEP vs Sustained Inflation in Bariatric Surgery Patients · NA · recruiting
- NCT06511310 — Exercise, Brain Activity, and Weight Maintenance · NA · recruiting
- NCT05966727 — Exploratory Evaluation of the Effect of Cholestyramine on Serum Levels of POPs in Obese Female Patients · NA · recruiting
- NCT06915558 — Modulation of the Inflammatory Response in Bariatric Surgery · recruiting
- NCT06689241 — Rivaroxaban Versus Enoxaparin for Prophylaxis of Venous Thromboembolism in Bariatric Surgery · NA · recruiting
Other University of Trieste trials
Trials by the same sponsor.
- NCT07430046 — Repurposing Mirtazapine in Rett Syndrome · Phase 2 · recruiting
- NCT07006571 — At-home Treatment With Cortico-spinal tDCS for Amyotrophic Lateral Sclerosis · NA · recruiting
- NCT06331416 — Multiparametric Home Telemonitoring of Patients With Chronic Obstructive Pulmonary Disease Exacerbation · NA · recruiting
- NCT05984095 — Multiple Sclerosis Pelvic Floor Telerehabilitation · NA · completed
- NCT06433856 — Neuromuscular Responses to Recovery Techniques · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03975348 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Trieste
- Last refreshed: 30 July 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03975348.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing